SUMMARY Spontaneous (NK cell) and antibody-dependent (K cell) cytotoxicity were investigated in 39 patients with systemic sclerosis (SS) and compared with that found in 52 normal controls. "Cr-labelled Chang liver cells were used as targets in assays utilising both whole blood (WB) and peripheral blood mononuclear cells (PBM) as effectors. Patients with SS, who were severely affected by extensive visceral disease, were found to have significant impairment of both NK (p<0 005; p<O005) and K (p<O0OO1; p<O005) cell cytotoxicity by both effector systems, when compared with normal controls. These findings, which seem to be part of a wider defect in cell-mediated immunity, may provide a possible explanation for the described association of malignancy with systemic sclerosis. 
There is increasing evidence that immunological abnormalities are an important feature of systemic sclerosis. Humoral abnormalities, such as a high incidence of autoantibodies' 2 and rheumatoid factor3 have been recognised for some time. More recently interest in abnormalities of cell-mediated immunity has been stimulated by the description of increased lymphocyte cytotoxicity for cultured fibroblasts45 and the recognition of abnormalities of thymusdependent (T) lymphocytes in patients severely affected by the disease.6 Further interest in cellmediated mechanisms has come from the realisation that graft-versus-host disease in both experimental animals7 and man can be followed by the development of scleroderma-like lesions.8 I Recent studies have, however, failed to confirm the presence of increased lymphocyte cytotoxicity for cultured target cells.0 " The present investigation of spontaneous or natural killer (NK cell) lymphocyte cytotoxicity for Chang liver cells was undertaken, therefore, as the first stage of a series of investigations into cytotoxic mechanisms in systemic sclerosis.
Materials and methods
Thirty-nine patients with systemic sclerosis (34 women, 5 men; mean age 54-8 ± 12-7 years) were Accepted for publication 16 June 1981. Correspondence to Dr J. K. Wright, Department of Medicine, Clinical Sciences Centre, Northern General Hospital, Sheffield S5 7AU. studied. Five of the patients were receiving treatment with immunosuppressive drugs (prednisolone, penicillamine, or azathioprine). Raynaud's phenomenon and acrosclerosis were constant features, and all patients were assessed for the extent of systemic involvement by the disease using previously described investigational criteria6 to allocate points and so produce a 'disease score' for each patient. On this basis patients with systemic sclerosis were divided into categories of mild (disease score 0-5; 23 women, 3 men; mean age 56 9 + 11-8 years) and severe (disease score 6-17; 11 women, 2 men; mean age 50 4 + 14-5 years) disease.
The controls consisted of 52 normal healthy volunteers (25 women, 27 men; mean age 39-8 + 14-8 years).
Spontaneous (NK cell) and antibody-dependent lymphocyte (K cell) cytotoxicity. These assays were performed as previously described"2 with 5'Cr K CELL SPECIFIC CYTOTOXICITY (LOGIO) Fig. 4 The relationship between spontaneous lymphocyte-mediated (NK cell) cytotoxicity and antibody-dependent lymphocyte (K cell) cytotoxicity for Chang liver cells (20 000/ml) using peripheral blood mononuclear cells (500 000/ml) in normal controls (r = 0-64, p<0001). labelled Chang liver cells as targets and both heparinised whole blood and purified peripheral blood mononuclear cells (PBM) as effector systems. NK cell cytotoxicity was expressed as percentage specific cytotoxicity after the 18 hour incubation of otherwise unmodified triplicate cultures of target and effector cells, while K cell cytotoxicity was similarly calculated for cultures to which had been added an optimal amount of rabbit anti-Chang cell serum. 12 The cytotoxicity data were analysed by the Mann-Whitney ranking test. The relationship between NK cell and K cell cytotoxicity in both whole blood and PBM assays was examined by regression analysis following log10 conversion of the data.
Results
Spontaneous (NK cell) cytotoxicity. Comparison of NK cell cytotoxicity in both whole blood and PBM assays revealed some correlation which was more evident in patients with systemic sclerosis (Table 1 , r = 0-44, p<0-01) than in the controls (Table 1 , r = 0-27, p = 0-05). Nevertheless, patients with severe systemic sclerosis showed reduced NK cell cytotoxicity in both whole blood (p<0-005) and PBM assays (p<O-O5) when compared with the normal controls, whereas the corresponding cytotoxic responses of mildly affected patients showed no such reduction (Fig. 1 Patients with severe systemic sclerosis again showed reduced K cell cytotoxicity in both whole blood (p = 0-001) and PBM assays (p<O-O5) when compared with normal controls, in contrast, once more, to the normal responses of the mildly affected patients (Fig. 2) .
Correlation of spontaneous (NK cell) and antibody-dependent lymphocyte (K cell) cytotoxicity. Comparison of NK cell and K cell cytotoxicity in both whole blood and PBM assays revealed good correlations in both controls (Fig. 3 , r = 0-70, p<O-OO1; Fig. 4 , r = 0-64, p<O-00l) and patients with systemic sclerosis (Fig. 5 , r = 0-82, p<O-OO1; Fig. 6 With this background the findings of the present investigation are of 3-fold interest. Firstly, the conclusion that patients severely affected by systemic sclerosis have reduced NK cell activity is in accord with earlier observations of reduced T cell numbers and mitogen responsiveness in the disease.6 The maintenance of a good correlation between NK and K cell cytotoxicity in this study is in keeping with previous findings in normal controls, even though there is now evidence that the lymphocyte subpopulations mediating these 2 types of cytotoxicity are to some extent distinct"4 and can be distinguished in some disease states.1" Secondly, the finding ot impaired NK cell cytotoxicity in systemic sclerosis may also have a practical relevance. It has been suggested that NK cells are an important component of immune surveillance mechanisms against the development of tumours."6 There is growing support for this hypothesis in animal models,17 18 while in man depressed NK cell function (as well as other immunological abnormalities) and an increased incidence of malignancy are found in diseases such as Wiskott-Aldrich syndrome, ataxia telangiectasia,"9 and kidney allograft recipients on immunosuppressive therapy.15 An increased incidence of pulmonary tumours20 and perhaps more general malignancy21 has also been reported in systemic sclerosis, and our current findings provide a possible explanation for these associations.
Finally, the observation of low NK cell activity in patients severely affected by systemic sclerosis may also be important in relation to assays for antigen specific T cell cytotoxicity. Failure to take into account the 'background' effect of NK cell cytotoxicity may mask the detection of more specific T cell mediated effects. In illustration of this point Svedmyr and Jondal22 found that it was necessary to remove a proportion of the NK cells before it was possible to detect antigen specific T cell cytotoxicity to EB virus infected cells in patients with infectious mononucleosis. It is therefore possible that the failure to take into account this masking effect of NK cell activity may account for the failure of recent studies to confirm the earlier reports4'5 of increased lymphocyte cytotoxicity in systemic sclerosis. As both experimental7 and human graft-versus-host disease89 may be complicated by sclerodermatous changes, further investigation of cytotoxic mechanisms in systemic sclerosis using fractionated lymphocyte subpopulations would certainly seem to be justified and could shed further light on the pathogenesis of the disorder. 
